BPL-003 — Initial data
Q4 2026
Phase 2a Part 4 (two ‑ dose induction + SSRIs) cohort initial data on track for Q4 2026.Source filing
ATAIBECKLEY INC · Data as of 2026-09-08
Q4 2026
Phase 2a Part 4 (two ‑ dose induction + SSRIs) cohort initial data on track for Q4 2026.Source filing
Q4 2026
VLS-01 (TRD): Elumina Phase 2 topline results anticipated in Q4 2026.Source filing
Early 2029
Early 2029: BPL-003 Phase 3 topline readoutsSource filing